60 related articles for article (PubMed ID: 7585570)
1. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer.
Riggins GJ; Markowitz S; Wilson JK; Vogelstein B; Kinzler KW
Cancer Res; 1995 Nov; 55(22):5184-6. PubMed ID: 7585570
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
[TBL] [Abstract][Full Text] [Related]
3. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.
Praml C; Amler LC; Dihlmann S; Finke LH; Schlag P; Schwab M
Oncogene; 1998 Oct; 17(15):2009-12. PubMed ID: 9788445
[TBL] [Abstract][Full Text] [Related]
4. Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours.
Tomlinson IP; Beck NE; Neale K; Bodmer WF
Ann Hum Genet; 1996 Sep; 60(5):369-76. PubMed ID: 8912789
[TBL] [Abstract][Full Text] [Related]
5. Human homologue of a candidate for the Mom1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35-36.1/D1S199.
Praml C; Savelyeva L; Le Paslier D; Siracusa LD; Buchberg AM; Schwab M; Amler LC
Cancer Res; 1995 Dec; 55(23):5504-6. PubMed ID: 7585622
[TBL] [Abstract][Full Text] [Related]
6. Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis.
Dobbie Z; Müller H; Scott RJ
Hum Genet; 1996 Sep; 98(3):386-90. PubMed ID: 8707313
[TBL] [Abstract][Full Text] [Related]
7. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains.
Kennedy BP; Payette P; Mudgett J; Vadas P; Pruzanski W; Kwan M; Tang C; Rancourt DE; Cromlish WA
J Biol Chem; 1995 Sep; 270(38):22378-85. PubMed ID: 7673223
[TBL] [Abstract][Full Text] [Related]
8. Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2.
Cupillard L; Koumanov K; Mattéi MG; Lazdunski M; Lambeau G
J Biol Chem; 1997 Jun; 272(25):15745-52. PubMed ID: 9188469
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of a gene encoding the Drosophila melanogaster phospholipase A2.
Ryu Y; Oh Y; Yoon J; Cho W; Baek K
Biochim Biophys Acta; 2003 Aug; 1628(3):206-10. PubMed ID: 12932833
[TBL] [Abstract][Full Text] [Related]
10. Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines.
Haluska FG; Thiele C; Goldstein A; Tsao H; Benoit EP; Housman D
Int J Cancer; 1997 Jul; 72(2):337-9. PubMed ID: 9219842
[TBL] [Abstract][Full Text] [Related]
11. [Localization of a tumor suppressor gene distal to D22S270 in colorectal cancers].
Duriez C; Schmitz A; Fouchet P; Buecher B; Thuille B; Lerebours F; Léger R; Boman F; Fléjou JF; Monges G; Paraf F; Bedossa P; Sabourin JC; Salmon RJ; Laurent-Puig P; Thomas G; Olschwang S
Gastroenterol Clin Biol; 1997; 21(5):358-64. PubMed ID: 9208010
[TBL] [Abstract][Full Text] [Related]
12. Cloning and recombinant expression of a novel mouse-secreted phospholipase A2.
Valentin E; Koduri RS; Scimeca JC; Carle G; Gelb MH; Lazdunski M; Lambeau G
J Biol Chem; 1999 Jul; 274(27):19152-60. PubMed ID: 10383420
[TBL] [Abstract][Full Text] [Related]
13. No SMAD4 hypermethylation in colorectal cancer.
Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer.
Praml C; Finke LH; Herfarth C; Schlag P; Schwab M; Amler L
Oncogene; 1995 Oct; 11(7):1357-62. PubMed ID: 7478557
[TBL] [Abstract][Full Text] [Related]
15. Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis.
Markova M; Koratkar RA; Silverman KA; Sollars VE; MacPhee-Pellini M; Walters R; Palazzo JP; Buchberg AM; Siracusa LD; Farber SA
Oncogene; 2005 Sep; 24(42):6450-8. PubMed ID: 16007193
[TBL] [Abstract][Full Text] [Related]
16. Human colorectal cancer: high frequency of deletions at chromosome 1p35.
Leister I; Weith A; Brüderlein S; Cziepluch C; Kangwanpong D; Schlag P; Schwab M
Cancer Res; 1990 Nov; 50(22):7232-5. PubMed ID: 1977517
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the secretory phospholipase A2 gene, a candidate of Mom1 gene, in neuroblastomas.
Kawamata N; Seriu T; Bartram CR; Koeffler HP
Cancer Lett; 1997 Jan; 111(1-2):71-5. PubMed ID: 9022130
[TBL] [Abstract][Full Text] [Related]
18. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
MacPhee M; Chepenik KP; Liddell RA; Nelson KK; Siracusa LD; Buchberg AM
Cell; 1995 Jun; 81(6):957-66. PubMed ID: 7781071
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.
Thiagalingam S; Lengauer C; Leach FS; Schutte M; Hahn SA; Overhauser J; Willson JK; Markowitz S; Hamilton SR; Kern SE; Kinzler KW; Vogelstein B
Nat Genet; 1996 Jul; 13(3):343-6. PubMed ID: 8673134
[TBL] [Abstract][Full Text] [Related]
20. p300 gene alterations in colorectal and gastric carcinomas.
Muraoka M; Konishi M; Kikuchi-Yanoshita R; Tanaka K; Shitara N; Chong JM; Iwama T; Miyaki M
Oncogene; 1996 Apr; 12(7):1565-9. PubMed ID: 8622873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
